BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today announced that 24 key data abstracts will be presented during the 27th annual European Academy of Dermatology and Venerology (EADV) Congress in Paris this week.
“Atopic dermatitis and psoriasis are two of the most common yet debilitating skin diseases that can have a profound impact on the quality of lives of people around the world, so there is still a huge unmet need for more and better treatment options,” said Kim Domela Kjøller, EVP of Global R&D at LEO Pharma A/S. “We’re excited about the scientific data being presented this week at the EADV as we continue our mission to develop new, innovative therapies to help patients achieve healthy skin.”
Please see the full press release text attached.